Italia markets closed

BMY Jan 2026 33.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
12,500,00 (0,00%)
Alla chiusura: 03:29PM EDT
Schermo intero
Chiusura precedente12,50
Aperto12,50
Denaro12,20
Lettera13,45
Prezzo d'esercizio33,00
Scadenza2026-01-16
Min-Max giorno12,50 - 12,50
Contratto - Min-MaxN/D
Volume5
Open Interest53
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri